AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 85, Issue 12 1706-1709, Copyright © 1995 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenthal, S
Right arrow Articles by Chen, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenthal, S
Right arrow Articles by Chen, R
The reporting sensitivities of two passive surveillance systems for vaccine adverse events.

S Rosenthal and R Chen

National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA.

To evaluate reporting sensitivities for vaccine adverse events, reporting rates were estimated by dividing the number of events reported to the Monitoring System for Adverse Events Following Immunization and the Vaccine Adverse Event Reporting System in a given period by the number of doses administered or distributed during the same period. Reporting sensitivity was calculated as the ratio of the rates at which events were reported to each passive surveillance system (numerator) and occurred in controlled studies (denominator). Reporting sensitivities were generally better in the public sector than in the private sector. The significant underreporting of known outcomes, together with the nonspecific nature of most adverse event reports, highlights the limitations of passive surveillance systems in assessing the incidence of vaccine adverse events.




This article has been cited by other articles:


Home page
J. Am. Med. Inform. Assoc.Home page
V. L. Hinrichsen, B. Kruskal, M. A. O'Brien, T. A. Lieu, R. Platt, and Vaccine Safety Datalink Team
Using Electronic Medical Records to Enhance Detection and Reporting of Vaccine Adverse Events
J. Am. Med. Inform. Assoc., November 1, 2007; 14(6): 731 - 735.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. R. Mahoney, D. J. Sargent, M. J. O'Connell, R. M. Goldberg, P. Schaefer, and J. C. Buckner
Dealing With a Deluge of Data: An Assessment of Adverse Event Data on North Central Cancer Treatment Group Trials
J. Clin. Oncol., December 20, 2005; 23(36): 9275 - 9281.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. S. Izurieta, P. Haber, R. P. Wise, J. Iskander, D. Pratt, C. Mink, S. Chang, M. M. Braun, and R. Ball
Adverse Events Reported Following Live, Cold-Adapted, Intranasal Influenza Vaccine
JAMA, December 7, 2005; 294(21): 2720 - 2725.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. G. Casey, J. K. Iskander, M. H. Roper, E. E. Mast, X.-J. Wen, T. J. Torok, L. E. Chapman, D. L. Swerdlow, J. Morgan, J. D. Heffelfinger, et al.
Adverse Events Associated With Smallpox Vaccination in the United States, January-October 2003
JAMA, December 7, 2005; 294(21): 2734 - 2743.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. W. McMahon, J. Iskander, P. Haber, S. Chang, E. J. Woo, M. M. Braun, and R. Ball
Adverse Events After Inactivated Influenza Vaccination Among Children Less Than 2 Years of Age: Analysis of Reports From the Vaccine Adverse Event Reporting System, 1990-2003
Pediatrics, February 1, 2005; 115(2): 453 - 460.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. Haber, F. DeStefano, F. J. Angulo, J. Iskander, S. V. Shadomy, E. Weintraub, and R. T. Chen
Guillain-Barre Syndrome Following Influenza Vaccination
JAMA, November 24, 2004; 292(20): 2478 - 2481.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. P. Wise, J. Iskander, R. D. Pratt, S. Campbell, R. Ball, R. P. Pless, and M. M. Braun
Postlicensure Safety Surveillance for 7-Valent Pneumococcal Conjugate Vaccine
JAMA, October 13, 2004; 292(14): 1702 - 1710.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. K. Parker, B. Schwartz, J. Todd, and L. K. Pickering
Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data
Pediatrics, September 1, 2004; 114(3): 793 - 804.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. Haber, R. T. Chen, L. R. Zanardi, G. T. Mootrey, R. English, M. M. Braun, and the VAERS Working Group
An Analysis of Rotavirus Vaccine Reports to the Vaccine Adverse Event Reporting System: More Than Intussusception Alone?
Pediatrics, April 1, 2004; 113(4): e353 - e359.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
V. Pool, M. M. Braun, J. M. Kelso, G. Mootrey, R. T. Chen, J. W. Yunginger, R. M. Jacobson, and P. M. Gargiullo
Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United States
Pediatrics, December 1, 2002; 110(6): e71 - 71.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
Adverse Events Associated With 17D-Derived Yellow Fever Vaccination--United States, 2001-2002
JAMA, November 27, 2002; 288(20): 2533 - 2535.
[Full Text] [PDF]


Home page
Br Med BullHome page
D M Salisbury, P C L Beverley, and E Miller
Vaccine programmes and policies
Br. Med. Bull., July 1, 2002; 62(1): 201 - 211.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. Verstraeten, A. L. Baughman, B. Cadwell, L. Zanardi, P. Haber, R. T. Chen, and the Vaccine Adverse Event Reporting System Team
Enhancing Vaccine Safety Surveillance: A Capture-Recapture Analysis of Intussusception after Rotavirus Vaccination
Am. J. Epidemiol., December 1, 2001; 154(11): 1006 - 1012.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. R. Zanardi, P. Haber, G. T. Mootrey, M. T. Niu, M. Wharton, and the VAERS Working Group
Intussusception Among Recipients of Rotavirus Vaccine: Reports to the Vaccine Adverse Event Reporting System
Pediatrics, June 1, 2001; 107(6): e97 - 97.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
W. A. Wattigney, G. T. Mootrey, M. M. Braun, and R. T. Chen
Surveillance for Poliovirus Vaccine Adverse Events, 1991 to 1998: Impact of a Sequential Vaccination Schedule of Inactivated Poliovirus Vaccine Followed by Oral Poliovirus Vaccine
Pediatrics, May 1, 2001; 107(5): 83e - 83.
[Abstract] [Full Text]


Home page
PediatricsHome page
T. S. DuVernoy, M. M. Braun, and the VAERS Working Group
Hypotonic-Hyporesponsive Episodes Reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998
Pediatrics, October 1, 2000; 106(4): 52e - 52.
[Abstract] [Full Text]


Home page
PediatricsHome page
M. M. Braun, G. Terracciano, M. E. Salive, D. A. Blumberg, P. E. Vermeer-de Bondt, H. Heijbel, G. Evans, P. A. Patriarca, and S. S. Ellenberg
Report of a US Public Health Service Workshop on Hypotonic-Hyporesponsive Episode (HHE) After Pertussis Immunization
Pediatrics, November 1, 1998; 102(5): 52e - 52.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Public Health Association